4//SEC Filing
Fernandes Peter 4
Accession 0001415889-22-000850
CIK 0001600132other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:31 PM ET
Size
5.6 KB
Accession
0001415889-22-000850
Insider Transaction Report
Form 4
Fernandes Peter
Chief Regulatory Officer
Transactions
- Award
Restricted Stock Units
2022-01-26+65,000→ 65,000 totalExercise: $0.00→ Common Stock (65,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Bellerophon common stock. The restricted stock units are scheduled to vest 50% on December 9, 2022 and 50% on December 8, 2023, as long as the reporting person remains in the service of Bellerophon through the respective vesting date.
- [F2]Not applicable.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001642618
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:31 PM ET
- Size
- 5.6 KB